TP53 and head and neck squamous cell carcinoma: A 4 cell line panel was initially selected with two p53 mutant (p53mt) HNSCC cell lines, HN4 and HN5, tested alongside the p53+/+ and p53−/− isogenic HCT116 cell lines.